SCHEMBL1817694

SCHEMBL1817694

COc1ccc(S(=O)(=O)N2CCOc3ccc(-c4ccc(C#N)c(OC)c4)cc32)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ NPC1 O15118 2/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ PKM P14618 4/20 0.40
▸ PKLR P30613 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CPT1A P50416 5/20 0.40
▸ CPT1B Q92523 4/20 0.40
▸ CPT2 P23786 3/20 0.40
▸ SCN9A Q15858 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816628 0.93 POLB (0.45) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1818459 0.90 POLB (0.47) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1818007 0.88 CYP2C9 (0.56) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1818577 0.88 NPC1 (0.58) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1819920 0.87 NPC1 (0.47) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1818967 0.87 CYP2C9 (0.48) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1816318 0.87 NPC1 (0.47) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1820258 0.86 NPC1 (0.45) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1818733 0.85 CYP2C9 (0.47) POLBCYP3A4CYP2D6NPC1CYP2C9
SCHEMBL1819412 0.85 NPC1 (0.45) POLBCYP3A4CYP2D6NPC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback